Search for reporting guidelines

Browse for reporting guidelines by selecting one or more of these drop-downs:

Study type Please select...Animal pre-clinical researchArtificial intelligence/Machine learning studiesClinical practice guidelinesDiagnostic and prognostic studiesEconomic evaluationsExperimental studiesLetters to the editor/CorrespondenceMixed methods studiesObservational studiesPatent landscapesQualitative researchQuality improvement studiesReliability and agreement studiesStudy protocolsSystematic reviews/Meta-analyses/Reviews/HTA/Overviews and Clinical area Please select...AllergyAnaesthesiaAudiovestibular medicineBehavioural medicineCardiovascular medicineComplementary and alternative medicineDentistryDermatologyEmergency medicineGastroenterologyGeneticsHaematologyHealth informaticsHepatologyInfectious diseasesMedical educationNeurologyNuclear medicineNutrition and dieteticsObstetrics and gynaecologyOccupational therapyOncologyOphthalmologyPaediatricsPalliative carePathologyPharmaceutical medicinePhysiotherapyPrimary carePsychiatryPsychologyPublic healthRadiologyRehabilitation medicineRenal medicineRespiratory medicineRheumatologySport and exercise medicineSurgeryToxicologyTropical medicineUrology and Section of report Please select...AbstractAcknowledgementsAppendixBiospecimen/bioresource informationConference paper/abstractConflict of interestDataEthical issues (consent etc.)Figures/GraphsFundingHarms/adverse effects/safety dataImagesIntervention (exposure)Narrative sections (discussion etc.)Outcomes (variables)Procedure/MethodProtocol-whole reportResearch recommendationsResultsStatistical analysis plan-whole reportStatistical methods and analysesStudy characteristics (participants etc.)Terminology/definitionsTitleWhole report Or search with free text

We recommend searching for reporting guidelines in English

Start again | Help

Displaying 648 reporting guidelines found.

Most recently added records are displayed first.

1
• LETter To the EditoR Standards (LETTERS) : Considerations for Authors, Reviewers, and Editors
  
2
• CAse-BAsed REview sTandards (CABARET) : Considerations for Authors, Reviewers, and Editors
  
3
• A consensus guideline on preferred items for reporting case series in homeopathy: The PITCH statement
  
4
• Reporting guidelines for evidence-based practice projects: A Delphi study and publication checklist
  
5
• REFORMS : Consensus-based Recommendations for Machine-learning-based Science
  
6
• Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group
  
7
• Guideline for RSA and CT-RSA implant migration measurements: an update of standardizations and recommendations
  
8
• Publication guidelines for human heart rate and heart rate variability studies in psychophysiology -Part 1: Physiological underpinnings and foundations of measurement
  
9
• Standardized reporting on studies of psychiatric pharmacist interventions
  
10
• PRIDASE 2024 guidelines for reporting diagnostic accuracy studies in endodontics: A consensus-based development
  
11
• Enhancing the quality of evidence, comparability, and reproducibility in ventriculoatrial shunt research for normal pressure hydrocephalus: A systematic review and VAS-NPH reporting guideline
  
12
• Development and validation of observational and qualitative study protocol reporting checklists for novice researchers (ObsQual checklist)
  
13
• Chec KAP : A Checklist for Reporting a Knowledge, Attitude, and Practice (KAP) Study
  
14
• A Reporting Checklist for Discrete Choice Experiments in Health: The DIRECT Checklist
  
15
• Improving laboratory animal genetic reporting: LAG-R guidelines
  
16
• The OHStat Guidelines for Reporting Observational Studies and Clinical Trials in Oral Health Research: Manuscript Checklist
  
17
• Reporting Conflicts of Interest and Funding in Health Care Guidelines: The RIGHT-COI &F Checklist
  
18
• Reporting guidelines for precision medicine research of clinical relevance: the Be PRECISE checklist
  
19
• Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate) : extension checklist with explanation and elaboration
  
20
• Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate) : extension checklist with explanation and elaboration
  
21
• Supporting best practice in reflexive thematic analysis reporting in Palliative Medicine: A review of published research and introduction to the Reflexive Thematic Analysis Reporting Guidelines (RTARG)
  
22
• TRIPLE C reporting principles for case study evaluations of the role of context in complex interventions
  
23
• Guideline for reporting systematic reviews of outcome measurement instruments (OMIs) : PRISMA-COSMIN for OMIs 2024
  
24
• Consolidated Health Economic Evaluation Reporting Standards for Interventions that use Artificial Intelligence (CHEERS-AI)
  
25
• The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV) : Development and Statement
  
26
• The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE)
  
27
• Consensus reporting guidelines to address gaps in descriptions of ultra-rare genetic conditions
  
28
• Biofield therapies: Guidelines for reporting clinical trials
  
29
• The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report
  
30
• REPORT-SCS : minimum reporting standards for spinal cord stimulation studies in spinal cord injury
  
31
• CARE-radiology statement explanation and elaboration: reporting guideline for radiological case reports
  
32
• Trial Forge Guidance 4: a guideline for reporting the results of randomised Studies Within A Trial (SWATs)
  
33
• The RETRIEVE Checklist for Studies Reporting the Elicitation of Stated Preferences for Child Health -Related Quality of Life
  
34
• We don’t know what you did last summer. On the importance of transparent reporting of reaction time data pre-processing
  
35
• Introducing So NHR-Reporting guidelines for Social Networks In Health Research
  
36
• Reporting standard for describing first responder systems, smartphone alerting systems, and AED networks
  
37
• The reporting checklist for Chinese patent medicine guidelines: RIGHT for CPM
  
38
• The SHARE : SHam Acupuncture REporting guidelines and a checklist in clinical trials
  
39
• REPCAN : Guideline for REporting Population-based CANcer Registry Data
  
40
• The Test Adaptation Reporting Standards (TARES) : reporting test adaptations
  
41
• ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi
  
42
• Consolidated Reporting Guidelines for Prognostic and Diagnostic Machine Learning Modeling Studies: Development and Validation
  
43
• Development of the Reporting Infographics and Visual Abstracts of Comparative studies (RIVA-C) checklist and guide
  
44
• Preliminary guideline for reporting bibliometric reviews of the biomedical literature (BIBLIO) : a minimum requirements
  
45
• Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit-risk assessment: the BRAINS study including expert workshop
  
46
• Preferred Reporting Items for Resistance Exercise Studies (PRIRES) : A Checklist Developed Using an Umbrella Review of Systematic Reviews
  
47
• ENLIGHT : A consensus checklist for reporting laboratory-based studies on the non-visual effects of light in humans
  
48
• Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement
  
49
• Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement
  
50
• Adjusting for Treatment Switching in Oncology Trials: A Systematic Review and Recommendations for Reporting
  
51
• Modeling Infectious Diseases in Healthcare Network (MInD-Healthcare) Framework for Describing and Reporting Multidrug-resistant Organism and Healthcare -Associated Infections Agent-based Modeling Methods
  
52
• LEVEL (Logical Explanations & Visualizations of Estimates in Linear mixed models): recommendations for reporting multilevel data and analyses
  
53
• Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting
  
54
• Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure
  
55
• Commentary: minimum reporting standards should be expected for preclinical radiobiology irradiators and dosimetry in the published literature
  
56
• Best practice guidelines for citizen science in mental health research: systematic review and evidence synthesis
  
57
• Evaluating the quality of studies reporting on clinical applications of stromal vascular fraction: A systematic review and proposed reporting guidelines (CLINIC-STRA-SVF)
  
58
• Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
  
59
• Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance
  
60
• ESMO Guidance for Reporting Oncology real -World evidence (GROW)
  
61
• A systematic review and cluster analysis approach of 103 studies of high-intensity interval training on cardiorespiratory fitness
  
62
• Generate Analysis -Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies
  
63
• Developing Consensus -Based Guidelines for Case Reporting in Aesthetic Medicine: Enhancing Transparency and Standardization
  
64
• MINIMAR (MINimum Information for Medical AI Reporting): Developing reporting standards for artificial intelligence in health care
  
65
• Presenting artificial intelligence, deep learning, and machine learning studies to clinicians and healthcare stakeholders: an introductory reference with a guideline and a Clinical AI Research (CAIR) checklist proposal
  
66
• Data Processing Strategies to Determine Maximum Oxygen Uptake: A Systematic Scoping Review and Experimental Comparison with Guidelines for Reporting
  
67
• Improving the Rigor of Mechanistic Behavioral Science: The Introduction of the Checklist for Investigating Mechanisms in Behavior -Change Research (CLIMBR)
  
68
• An analysis of reporting practices in the top 100 cited health and medicine-related bibliometric studies from 2019 to 2021 based on a proposed guidelines
  
69
• Improving the Reporting of Primary Care Research: Consensus Reporting Items for Studies in Primary Care-the CRISP Statement
  
70
• Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use
  
71
• Community-developed checklists for publishing images and image analyses
  
72
• Systematic Development of Standards for Mixed Methods Reporting in Rehabilitation Health Sciences Research
  
73
• Minimal reporting guideline for research involving eye tracking (2023 edition)
  
74
• CHEERS Value of Information (CHEERS-VOI) Reporting Standards – Explanation and Elaboration
  
75
• Initial Standardized Framework for Reporting Social Media Analytics in Emergency Care Research
  
76
• The adapted Autobiographical interview: A systematic review and proposal for conduct and reporting
  
77
• Paediatric Ureteroscopy (P-URS) reporting checklist: a new tool to aid studies report the essential items on paediatric ureteroscopy for stone disease
  
78
• Adult Ureteroscopy (A-URS) Checklist: A New Tool To Standardise Reporting in Endourology
  
79
• Recommendations for the development, implementation, and reporting of control interventions in efficacy and mechanistic trials of physical, psychological, and self-management therapies: the Co PPS Statement
  
80
• Reporting Eye-tracking Studies In DEntistry (RESIDE) checklist
  
81
• AdVi SHE : A Validation -Assessment Tool of Health -Economic Models for Decision Makers and Model Users
  
82
• i CHECK-DH : Guidelines and Checklist for the Reporting on Digital Health Implementations
  
83
• New reporting items and recommendations for randomized trials impacted by COVID- 19 and force majeure events: a targeted approach
  
84
• Development, explanation, and presentation of the Physical Literacy Interventions Reporting Template (PLIRT)
  
85
• Reporting guidelines for allergy and immunology survey research
  
86
• CheckList for EvaluAtion of Radiomics research (CLEAR) : a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSo MII
  
87
• Transparent reporting of multivariable prediction models for individual prognosis or diagnosis: checklist for systematic reviews and meta-analyses (TRIPOD-SRMA)
  
88
• Preferred Reporting Items for Complex Sample Survey Analysis (PRICSSA)
  
89
• Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations
  
90
• CORE-CERT Items as a Minimal Requirement for Replicability of Exercise Interventions: Results From Application to Exercise Studies for Breast Cancer Patients
  
91
• Recommendations for Reporting Machine Learning Analyses in Clinical Research
  
92
• ACURATE : A guide for reporting sham controls in trials using acupuncture
  
93
• Checklist for Artificial Intelligence in Medical Imaging (CLAIM) : 2024 Update
  
94
• STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM) : Extending the CONSORT statement
  
95
• Transparent reporting of multivariable prediction models developed or validated using clustered data: TRIPOD-Cluster checklist
  
96
• The SUPER reporting guideline suggested for reporting of surgical technique
  
97
• Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension
  
98
• Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension
  
99
• PROBE 2023 guidelines for reporting observational studies in Endodontics: A consensus-based development study
  
100
• CONFERD-HP : recommendations for reporting COmpeteNcy FramEwoRk Development in health professions
  
101
• Development of the ASSESS tool: a comprehenSive tool to Support rEporting and critical appraiSal of qualitative, quantitative, and mixed methods implementation reSearch outcomes
  
102
• Guiding document analyses in health professions education research
  
103
• Evidence-based statistical analysis and methods in biomedical research (SAMBR) checklists according to design features
  
104
• Social Accountability Reporting for Research (SAR 4Research): checklist to strengthen reporting on studies on social accountability in the literature
  
105
• How to Report Data on Bilateral Procedures and Other Issues with Clustered Data: The CLUDA Reporting Guidelines
  
106
• Best practice guidance and reporting items for the development of scoping review protocols
  
107
• Establishing reporting standards for participant characteristics in post-stroke aphasia research: An international e -Delphi exercise and consensus meeting
  
108
• STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting
  
109
• Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research -The ConPhy MP-Guidelines
  
110
• Advising on Preferred Reporting Items for patient-reported outcome instrument development: the PRIPROID
  
111
• Recommendations for reporting the results of studies of instrument and scale development and testing
  
112
• Methodical approaches to determine the rate of radial muscle displacement using tensiomyography: A scoping review and new reporting guideline
  
113
• Methods for developing and reporting living evidence synthesis
  
114
• Bayesian Analysis Reporting Guidelines
  
115
• Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement
  
116
• The Do CTRINE Guidelines: Defined Criteria To Report INnovations in Education
  
117
• Development of guidelines to reduce, handle and report missing data in palliative care trials: A multi-stakeholder modified nominal group technique
  
118
• The RIPI-f (Reporting Integrity of Psychological Interventions delivered face-to-face) checklist was developed to guide reporting of treatment integrity in face-to-face psychological interventions
  
119
• The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) Global Surgical Collaboration Project: Development of Criteria for Reporting Adverse Events During Surgical Procedures and Evaluating Their Impact on the Postoperative Course
  
120
• CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research
  
121
• A Reporting Tool for Adapted Guidelines in Health Care: The RIGHT-Ad@pt Checklist
  
122
• Development of a reporting guideline for systematic reviews of animal experiments in the field of traditional Chinese medicine
  
123
• TIDieR-telehealth : precision in reporting of telehealth interventions used in clinical trials – unique considerations for the Template for the Intervention Description and Replication (TIDieR) checklist
  
124
• Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS
  
125
• Murine models of radiation cardiotoxicity: a systematic review and recommendations for future studies
  
126
• Systematic Review and Meta -Analysis of Outcomes After Operative Treatment of Aberrant Subclavian Artery Pathologies and Suggested Reporting Items
  
127
• Reporting standards for psychological network analyses in cross-sectional data
  
128
• Reporting ChAracteristics of cadaver training and sUrgical studies: The CACTUS guidelines
  
129
• EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology
  
130
• Methods and Applications of Social Media Monitoring of Mental Health During Disasters: Scoping Review
  
131
• Position Statement on Exercise Dosage in Rheumatic and Musculoskeletal Diseases: The Role of the IMPACT-RMD Toolkit
  
132
• A checklist for assessing the methodological quality of concurrent t ES-fMRI studies (ContES checklist): a consensus study and statement
  
133
• Application of Mixed Methods in Health Services Management Research: A Systematic Review
  
134
• Methodological standards for conducting and reporting meta-analyses: Ensuring the replicability of meta-analyses of pharmacist-led medication review
  
135
• A scoping review of the use of ethnographic approaches in implementation research and recommendations for reporting
  
136
• The Chest Wall Injury Society Recommendations for Reporting Studies of Surgical Stabilization of Rib Fractures
  
137
• How to Report Light Exposure in Human Chronobiology and Sleep Research Experiments
  
138
• Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI
  
139
• Use of actigraphy for assessment in pediatric sleep research
  
140
• EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology
  
141
• International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020)
  
142
• Refining the CRiSPHe (checklist for reporting research using a simulated patient methodology in Health): a Delphi study
  
143
• Conceptual Ambiguity Surrounding Gamification and Serious Games in Health Care: Literature Review and Development of Game -Based Intervention Reporting Guidelines (GAMING)
  
144
• Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines
  
145
• Six practical recommendations for improved implementation outcomes reporting
  
146
• Recommendations and publication guidelines for studies using frequency domain and time-frequency domain analyses of neural time series
  
147
• EVIDENCE Publication Checklist for Studies Evaluating Connected Sensor Technologies: Explanation and Elaboration
  
148
• An extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines: RIGHT for INT
  
149
• Rasch Reporting Guideline for Rehabilitation Research (RULER) : The RULER Statement
  
150
• Using qualitative research to develop an elaboration of the TIDieR checklist for interventions to enhance vaccination communication: short report
  
151
• Preliminary Minimum Reporting Requirements for In -Vivo Neural Interface Research: I. Implantable Neural Interfaces
  
152
• Standardized Reporting of Machine Learning Applications in Urology: The STREAM-URO Framework
  
153
• Guidance for publishing qualitative research in informatics
  
154
• Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols
  
155
• A Scoping Review of Four Decades of Outcomes in Nonsurgical Root Canal Treatment, Nonsurgical Retreatment, and Apexification Studies: Part 3 -A Proposed Framework for Standardized Data Collection and Reporting of Endodontic Outcome Studies
  
156
• Health -Economic Analyses of Diagnostics: Guidance on Design and Reporting
  
157
• Reporting guidelines for human microbiome research: the STORMS checklist
  
158
• Smartphone -Delivered Ecological Momentary Interventions Based on Ecological Momentary Assessments to Promote Health Behaviors: Systematic Review and Adapted Checklist for Reporting Ecological Momentary Assessment and Intervention Studies
  
159
• A Systematic Review of Methods and Procedures Used in Ecological Momentary Assessments of Diet and Physical Activity Research in Youth: An Adapted STROBE Checklist for Reporting EMA Studies (CREMAS)
  
160
• Reporting Data on Auditory Brainstem Responses (ABR) in Rats: Recommendations Based on Review of Experimental Protocols and Literature
  
161
• Heterogeneity in the Identification of Potential Drug -Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations
  
162
• Development of the CLARIFY (CheckList stAndardising the Reporting of Interventions For Yoga) guidelines: a Delphi study
  
163
• Early phase clinical trials extension to guidelines for the content of statistical analysis plans
  
164
• PRESENT 2020: Text Expanding on the Checklist for Proper Reporting of Evidence in Sport and Exercise Nutrition Trials
  
165
• Intraoperative fluorescence diagnosis in the brain: a systematic review and suggestions for future standards on reporting diagnostic accuracy and clinical utility
  
166
• Checklist for Theoretical Report in Epidemiological Studies (CRT-EE) : explanation and elaboration
  
167
• STAndard Reporting of CAries Detection and Diagnostic Studies (STARCARDDS)
  
168
• Implementing the 27 PRISMA 2020 Statement items for systematic reviews in the sport and exercise medicine, musculoskeletal rehabilitation and sports science fields: the PERSiST (implementing Prisma in Exercise, Rehabilitation, Sport medicine and SporTs science) guidance
  
169
• Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement
  
170
• Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines
  
171
• Extending the CONSORT Statement to moxibustion
  
172
• Consensus-based recommendations for case report in Chinese medicine (CARC)
  
173
• Reporting Guidelines for Whole -Body Vibration Studies in Humans, Animals and Cell Cultures: A Consensus Statement from an International Group of Experts
  
174
• Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension
  
175
• A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement
  
176
• Social Innovation For Health Research (SIFHR) : Development of the SIFHR Checklist
  
177
• How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines
  
178
• REPORT-PFP : a consensus from the International Patellofemoral Research Network to improve REPORTing of quantitative PatelloFemoral Pain studies
  
179
• Reporting stAndards for research in PedIatric Dentistry (RAPID) : an expert consensus-based statement
  
180
• Improving the reporting quality of reliability generalization meta-analyses: The REGEMA checklist
  
181
• Evaluation of post-introduction COVID- 19 vaccine effectiveness: Summary of interim guidance of the World Health Organization
  
182
• Journal article reporting standards for quantitative research in psychology: The APA Publications and Communications Board task force report
  
183
• Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID- 19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement
  
184
• Describing deprescribing trials better: an elaboration of the CONSORT statement
  
185
• Comprehensive reporting of pelvic floor muscle training for urinary incontinence: CERT-PFMT
  
186
• International Olympic Committee Consensus Statement: Methods for Recording and Reporting of Epidemiological Data on Injury and Illness in Sports 2020 (Including the STROBE Extension for Sports Injury and Illness Surveillance (STROBE-SIIS))
  
187
• RIGHT for Acupuncture: An Extension of the RIGHT Statement for Clinical Practice Guidelines on Acupuncture
  
188
• The APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies
  
189
• Room Indirect Calorimetry Operating and Reporting Standards (RICORS 1.0): A Guide to Conducting and Reporting Human Whole -Room Calorimeter Studies
  
190
• COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures
  
191
• Ensuring best practice in genomics education and evaluation: reporting item standards for education and its evaluation in genomics (RISE 2 Genomics)
  
192
• A Consensus -Based Checklist for Reporting of Survey Studies (CROSS)
  
193
• CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE) : checklist with explanation and elaboration
  
194
• Preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for Abstracts): checklist, explanation, and elaboration
  
195
• An analysis of preclinical efficacy testing of antivenoms for sub -Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management
  
196
• Artificial intelligence in dental research: Checklist for authors, reviewers, readers
  
197
• EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs)
  
198
• PRIASE 2021 guidelines for reporting animal studies in Endodontology: a consensus-based development
  
199
• The reporting checklist for public versions of guidelines: RIGHT-PVG
  
200
• SQUIRE-EDU (Standards for QUality Improvement Reporting Excellence in Education): Publication Guidelines for Educational Improvement
  
201
• PRISMA-S : an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews
  
202
• Anaesthesia Case Report (ACRE) checklist: a tool to promote high-quality reporting of cases in peri-operative practice
  
203
• Strengthening tRansparent reporting of reseArch on uNfinished nursing CARE : The RANCARE guideline
  
204
• Journal article reporting standards for qualitative primary, qualitative meta-analytic, and mixed methods research in psychology: The APA Publications and Communications Board task force report
  
205
• Defining Group Care Programs: An Index of Reporting Standards
  
206
• Stakeholder analysis in health innovation planning processes: A systematic scoping review
  
207
• PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration
  
208
• PRISMA (Preferred Reporting Items for Systematic Reviews and Meta -Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020)
  
209
• Reporting gaps in immunization costing studies: Recommendations for improving the practice
  
210
• The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation
  
211
• Proposed Requirements for Cardiovascular Imaging -Related Machine Learning Evaluation (PRIME) : A Checklist: Reviewed by the American College of Cardiology Healthcare Innovation Council
  
212
• Benefit -Risk Assessment of Vaccines. Part II : Proposal Towards Consolidated Standards of Reporting Quantitative Benefit -Risk Models Applied to Vaccines (BRIVAC)
  
213
• BIAS : Transparent reporting of biomedical image analysis challenges
  
214
• Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist
  
215
• STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline
  
216
• TIDieR-Placebo : a guide and checklist for reporting placebo and sham controls
  
217
• Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension
  
218
• Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension
  
219
• The IDEAL Reporting Guidelines: A Delphi Consensus Statement Stage specific recommendations for reporting the evaluation of surgical innovation
  
220
• The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
  
221
• Reporting Guideline for Priority Setting of Health Research (REPRISE)
  
222
• Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist)
  
223
• PRICE 2020 guidelines for reporting case reports in Endodontics: a consensus-based development
  
224
• PRIRATE 2020 guidelines for reporting randomized trials in Endodontics: a consensus-based development
  
225
• Guidance for reporting intervention development studies in health research (GUIDED) : an evidence-based consensus study
  
226
• Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018)
  
227
• SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist
  
228
• Standards for reporting interventions in clinical trials of cupping (STRICTOC) : extending the CONSORT statement
  
229
• Pa CIR : A tool to enhance pharmacist patient care intervention reporting
  
230
• Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
  
231
• Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose
  
232
• Criteria for describing and evaluating training interventions in healthcare professions – CRe-DEPTH
  
233
• CONSORT extension for reporting N-of- 1 trials for traditional Chinese medicine (CENT for TCM) : Recommendations, explanation and elaboration
  
234
• Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist
  
235
• Consolidated criteria for strengthening reporting of health research involving indigenous peoples: the CONSIDER statement
  
236
• Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT
  
237
• Reporting guidelines on remotely collected electronic mood data in mood disorder (e MOOD)-recommendations
  
238
• CONSORT 2010 statement: extension to randomised crossover trials
  
239
• Reporting of Multi -Arm Parallel -Group Randomized Trials: Extension of the CONSORT 2010 Statement
  
240
• Microbiology Investigation Criteria for Reporting Objectively (MICRO) : a framework for the reporting and interpretation of clinical microbiology data
  
241
• Core Outcome Set -STAndardised Protocol Items: the COS-STAP Statement
  
242
• The Reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER) Checklist: A Joint Statement by the ERAS ® and ERAS ® USA Societies
  
243
• Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration
  
244
• Improving reporting of Meta -Ethnography : The e MERGe Reporting Guidance
  
245
• The Reporting Items for Patent Landscapes statement
  
246
• Reporting guidelines on how to write a complete and transparent abstract for overviews of systematic reviews of health care interventions
  
247
• The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)
  
248
• PRISMA Extension for Scoping Reviews (PRISMA-ScR) : Checklist and Explanation
  
249
• Systems Perspective of Amazon Mechanical Turk for Organizational Research: Review and Recommendations
  
250
• ESPACOMP Medication Adherence Reporting Guideline (EMERGE)
  
251
• Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension
  
252
• Reporting guidelines for implementation research on nurturing care interventions designed to promote early childhood development
  
253
• Strengthening the reporting of empirical simulation studies: Introducing the STRESS guidelines
  
254
• TIDieR-PHP : a reporting guideline for population health and policy interventions
  
255
• Guidelines for Inclusion of Patient -Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension
  
256
• Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement
  
257
• Structural brain development: A review of methodological approaches and best practices
  
258
• Improving the Development, Monitoring and Reporting of Stroke Rehabilitation Research: Consensus -Based Core Recommendations from the Stroke Recovery and Rehabilitation Roundtable
  
259
• Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements
  
260
• Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review
  
261
• Standards for UNiversal reporting of patient Decision Aid Evaluation studies: the development of SUNDAE Checklist
  
262
• Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies -Statement From ATVB Council
  
263
• Guidelines for the Content of Statistical Analysis Plans in Clinical Trials
  
264
• RECORDS : Improved reporting of Monte Carlo Radiation transport studies: Report of the AAPM Research Committee Task Group 268
  
265
• Ten simple rules for neuroimaging meta-analysis
  
266
• CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials
  
267
• Preferred Reporting Items for Overviews of systematic reviews including harms checklist: A pilot tool to be used for balanced reporting of benefits and harms
  
268
• Reporting Guidelines for the Use of Expert Judgement in Model -Based Economic Evaluations
  
269
• Standards for reporting chronic periodontitis prevalence and severity in epidemiologic studies: Proposed standards from the Joint EU / USA Periodontal Epidemiology Working Group
  
270
• Graphics and statistics for cardiology: designing effective tables for presentation and publication
  
271
• Guidelines for reporting meta-epidemiological methodology research
  
272
• Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0
  
273
• Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance
  
274
• Guidelines for Reporting on Latent Trajectory Studies (GRoLTS)
  
275
• AMWA ‒ EMWA ‒ ISMPP Joint Position Statement on the Role of Professional Medical Writers
  
276
• The STROCSS 2024 guideline: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery
  
277
• Unique identification of research resources in the biomedical literature: the Resource Identification Initiative (RRID)
  
278
• Checklist for One Health Epidemiological Reporting of Evidence (COHERE)
  
279
• STARD for Abstracts: essential items for reporting diagnostic accuracy studies in journal or conference abstracts
  
280
• GRIPP 2 reporting checklists: tools to improve reporting of patient and public involvement in research
  
281
• Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
  
282
• Improving the reporting of clinical trials of infertility treatments (IMPRINT) : modifying the CONSORT statement
  
283
• Improving the reporting of therapeutic exercise interventions in rehabilitation research
  
284
• Guidance to develop individual dose recommendations for patients on chronic hemodialysis
  
285
• A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines
  
286
• AHRQ Series on Complex Intervention Systematic Reviews – Paper 6: PRISMA-CI Extension Statement & Checklist
  
287
• Adaptation of the CARE Guidelines for Therapeutic Massage and Bodywork Publications: Efforts To Improve the Impact of Case Reports
  
288
• A review of published analyses of case-cohort studies and recommendations for future reporting
  
289
• Guidelines for reporting evaluations based on observational methodology
  
290
• Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies
  
291
• Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO) : Platelet -Rich Plasma and Mesenchymal Stem Cells
  
292
• CONSORT 2010 statement: extension checklist for reporting within person randomised trials
  
293
• CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration
  
294
• Methods and processes of developing the strengthening the reporting of observational studies in epidemiology – veterinary (STROBE-Vet) statement
  
295
• CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
  
296
• STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
  
297
• SPIRIT 2013 Statement: Defining standard protocol items for clinical trials
  
298
• Best Practices in Data Analysis and Sharing in Neuroimaging using MRI
  
299
• Latent Class Analysis: An example for reporting results
  
300
• Guidelines for Developing and Reporting Machine Learning Predictive Models in Biomedical Research: A Multidisciplinary View
  
301
• Clarity in Reporting Terminology and Definitions of Set End Points in Resistance Training
  
302
• An introduction to using Bayesian linear regression with clinical data
  
303
• Making economic evaluations more helpful for treatment choices in haemophilia
  
304
• Guideline for Reporting Interventions on Spinal Manipulative Therapy: Consensus on Interventions Reporting Criteria List for Spinal Manipulative Therapy (CIRCLe SMT)
  
305
• Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic review
  
306
• STARD-BLCM : Standards for the Reporting of Diagnostic accuracy studies that use Bayesian Latent Class Models
  
307
• A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement
  
308
• The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines
  
309
• The REFLECT statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety by modifying the CONSORT statement
  
310
• Reporting Items for Updated Clinical Guidelines: Checklist for the Reporting of Updated Guidelines (CheckUp)
  
311
• Preferred Reporting Items for the Development of Evidence-based Clinical Practice Guidelines in Traditional Medicine (PRIDE-CPG-TM) : Explanation and elaboration
  
312
• Standards for Reporting Implementation Studies (StaRI) Statement
  
313
• Preferred Reporting Of Case Series in Surgery (PROCESS) 2023 guidelines
  
314
• Consensus on Exercise Reporting Template (CERT) : Modified Delphi Study
  
315
• Development of the Anatomical Quality Assurance (AQUA) Checklist: guidelines for reporting original anatomical studies
  
316
• CONSORT 2010 statement: extension to randomised pilot and feasibility trials
  
317
• Core Outcome Set -STAndards for Reporting: The COS-STAR Statement
  
318
• Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement
  
319
• Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer -Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging
  
320
• Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group
  
321
• Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10 -Year Update
  
322
• Irreversible Electroporation (IRE) : Standardization of Terminology and Reporting Criteria for Analysis and Comparison
  
323
• Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review
  
324
• METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer
  
325
• Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations -A Report of a European School of Oncology Task Force
  
326
• Transcription factor HIF 1A: downstream targets, associated pathways, polymorphic hypoxia response element (HRE) sites, and initiative for standardization of reporting in scientific literature
  
327
• Eliciting the child’s voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient -Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative
  
328
• CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement
  
329
• REporting recommendations for tumour MARKer prognostic studies (REMARK)
  
330
• Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective
  
331
• Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST)
  
332
• A Checklist for Reporting Valuation Studies of Multi -Attribute Utility -Based Instruments (CREATE)
  
333
• Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI) : an extension of the STROBE statement for neonatal infection research
  
334
• The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines
  
335
• Development and validation of the guideline for reporting evidence-based practice educational interventions and teaching (GREET)
  
336
• Using theory of change to design and evaluate public health interventions: a systematic review
  
337
• Homeopathic clinical case reports: Development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline
  
338
• Reporting Guidelines for Health Care Simulation Research: Extensions to the CONSORT and STROBE Statements
  
339
• Guidelines for Reporting Articles on Psychiatry and Heart rate variability (GRAPH) : recommendations to advance research communication
  
340
• RAMESES II reporting standards for realist evaluations
  
341
• Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement
  
342
• Medical abortion reporting of efficacy: the MARE guidelines.
  
343
• Strengthening the Reporting of Observational Studies in Epidemiology—Nutritional Epidemiology (STROBE-nut) : An Extension of the STROBE Statement
  
344
• Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use
  
345
• The Single -Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement
  
346
• Consensus on Recording Deep Endometriosis Surgery: the CORDES statement
  
347
• Developing the Clarity and Openness in Reporting: E3-based (CORE) reference user manual for creation of clinical study reports in the era of clinical trial transparency
  
348
• SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee
  
349
• Definition and classification of intraoperative complications (CLASSIC) : Delphi study and pilot evaluation
  
350
• Improving research practice in rat orthotopic and partial orthotopic liver transplantation: a review, recommendation, and publication guide
  
351
• Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review
  
352
• Standardized outcomes reporting in metabolic and bariatric surgery
  
353
• Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting
  
354
• DELTA 2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial
  
355
• Transparent reporting of data quality in distributed data networks
  
356
• Quality of methods reporting in animal models of colitis
  
357
• Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (m ERA) checklist
  
358
• Quality of pain intensity assessment reporting: ACTTION systematic review and recommendations
  
359
• An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver -FibroSTARD standards
  
360
• STROBE-AMS : recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship
  
361
• Reporting guidelines for population pharmacokinetic analyses
  
362
• Recommendations for the improved effectiveness and reporting of telemedicine programs in developing countries: results of a systematic literature review
  
363
• Guidelines for the reporting of treatment trials for alcohol use disorders
  
364
• Development of the Standards of Reporting of Neurological Disorders (STROND) checklist: A guideline for the reporting of incidence and prevalence studies in neuroepidemiology
  
365
• A review of 40 years of enteric antimicrobial resistance research in Eastern Africa: what can be done better?
  
366
• Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT
  
367
• RiGoR: reporting guidelines to address common sources of bias in risk model development
  
368
• Reporting standards for guideline-based performance measures
  
369
• Utstein-style guidelines on uniform reporting of in-hospital cardiopulmonary resuscitation in dogs and cats
  
370
• Guidelines for reporting embedded recruitment trials
  
371
• PRISMA harms checklist: improving harms reporting in systematic reviews
  
372
• Developing a methodological framework for organisational case studies: a rapid review and consensus development process
  
373
• The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
  
374
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies
  
375
• A checklist to improve reporting of group-based behaviour-change interventions
  
376
• The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
  
377
• Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement
  
378
• A call for transparent reporting to optimize the predictive value of preclinical research
  
379
• Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders
  
380
• The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
  
381
• Setting number of decimal places for reporting risk ratios: rule of four
  
382
• Too many digits: the presentation of numerical data
  
383
• The CONSORT Statement: Application within and adaptations for orthodontic trials
  
384
• A structured approach to documenting a search strategy for publication: a 12 step guideline for authors
  
385
• Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group
  
386
• Standardized reporting guidelines for emergency department syncope risk-stratification research
  
387
• Designing and reporting case series in plastic surgery
  
388
• Disaster medicine reporting: the need for new guidelines and the CONFIDE statement
  
389
• Development and validation of reporting guidelines for studies involving data linkage
  
390
• A reporting guide for studies on individual differences in traffic safety
  
391
• Translating trial-based molecular monitoring into clinical practice: importance of international standards and practical considerations for community practitioners
  
392
• Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy
  
393
• A tool to analyze the transferability of health promotion interventions
  
394
• A new manner of reporting pressure results after glaucoma surgery
  
395
• Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine
  
396
• Recommendations for the reporting of foot and ankle models
  
397
• An introduction to standardized clinical nomenclature for dysmorphic features: the Elements of Morphology project
  
398
• Strengthening the Reporting of Observational Studies in Epidemiology for Respondent -Driven Sampling Studies: ‘ STROBE-RDS ’ Statement.
  
399
• CONSORT extension for reporting N-of- 1 trials (CENT) 2015 Statement
  
400
• A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies
  
401
• Reporting standards for literature searches and report inclusion criteria: making research syntheses more transparent and easy to replicate
  
402
• Preferred Reporting Items for Systematic Review and Meta -Analyses of individual participant data: the PRISMA-IPD Statement
  
403
• Evaluating complex interventions in end of life care: the MORECare statement on good practice generated by a synthesis of transparent expert consultations and systematic reviews
  
404
• Biospecimen reporting for improved study quality (BRISQ)
  
405
• Developing a guideline to standardize the citation of bioresources in journal articles (CoBRA)
  
406
• Reporting Guidelines for Clinical Pharmacokinetic Studies: The Clin PK Statement
  
407
• Using the spinal cord injury common data elements
  
408
• Guidelines for assessment of bone microstructure in rodents using micro-computed tomography
  
409
• Instrumental variable methods in comparative safety and effectiveness research
  
410
• Protecting the power of interventions through proper reporting
  
411
• Reporting of data from out-of-hospital cardiac arrest has to involve emergency medical dispatching – taking the recommendations on reporting OHCA the Utstein style a step further
  
412
• A position paper on standardizing the nonneoplastic kidney biopsy report
  
413
• Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations
  
414
• Reporting of interaction
  
415
• Head, neck, and brain tumor embolization guidelines
  
416
• Reporting outcomes of back pain trials: a modified Delphi study
  
417
• A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints
  
418
• Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data
  
419
• Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data
  
420
• Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data
  
421
• Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study
  
422
• Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet
  
423
• A new standardized format for reporting hearing outcome in clinical trials
  
424
• A consensus approach toward the standardization of back pain definitions for use in prevalence studies
  
425
• A proposed taxonomy of terms to guide the clinical trial recruitment process
  
426
• Minimum data elements for research reports on CFS
  
427
• Reporting standards for angiographic evaluation and endovascular treatment of cerebral arteriovenous malformations
  
428
• How to report low-level laser therapy (LLLT) /photomedicine dose and beam parameters in clinical and laboratory studies
  
429
• Common data elements for posttraumatic stress disorder research
  
430
• American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants
  
431
• Completeness of reporting of radiation therapy planning, dose, and delivery in veterinary radiation oncology manuscripts from 2005 to 2010
  
432
• Criteria for Reporting the Development and Evaluation of Complex Interventions in healthcare: revised guideline (CReDECI 2)
  
433
• TRIPOD + AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
  
434
• Preferred Reporting Items for Systematic Review and Meta -Analysis Protocols (PRISMA-P) 2015 statement
  
435
• Reporting guidance for violence risk assessment predictive validity studies: the RAGEE Statement
  
436
• Standards for reporting qualitative research: a synthesis of recommendations
  
437
• A systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting
  
438
• Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically
  
439
• Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology
  
440
• Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative.
  
441
• Strengthening the reporting of molecular epidemiology for infectious diseases (STROME-ID) : an extension of the STROBE statement
  
442
• Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
  
443
• Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries
  
444
• CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials
  
445
• The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development
  
446
• Documenting Clinical and Laboratory Images in Publications: The CLIP Principles
  
447
• ICMJE : Uniform Format for Disclosure of Competing Interests in ICMJE Journals
  
448
• Selection and presentation of imaging figures in the medical literature
  
449
• Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
  
450
• Finding What Works in Health Care: Standards for Systematic Reviews. Chapter 5 – Standards for Reporting Systematic Reviews
  
451
• Systematic Reviews. CRD ’s guidance for undertaking reviews in health care
  
452
• The Hu GENet ™ Hu GE Review Handbook, version 1.0. Guidelines for systematic review and meta-analysis of gene disease association studies
  
453
• Cochrane Handbook for Systematic Reviews of Interventions Version 6.1
  
454
• Writing for Publication in Veterinary Medicine. A Practical Guide for Researchers and Clinicians
  
455
• Publication of population data for forensic purposes
  
456
• Publication of population data of linearly inherited DNA markers in the International Journal of Legal Medicine
  
457
• Proposed definitions and criteria for reporting time frame, outcome, and complications for clinical orthopedic studies in veterinary medicine
  
458
• Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology
  
459
• Update of the stroke therapy academic industry roundtable preclinical recommendations
  
460
• Good laboratory practice: preventing introduction of bias at the bench
  
461
• Consensus-based reporting standards for diagnostic test accuracy studies for paratuberculosis in ruminants
  
462
• A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible
  
463
• The ARRIVE Guidelines 2.0: updated guidelines for reporting animal research
  
464
• International Society for Medical Publication Professionals Code of Ethics
  
465
• Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials
  
466
• What should be done to tackle ghostwriting in the medical literature?
  
467
• Electrodermal activity at acupoints: literature review and recommendations for reporting clinical trials
  
468
• Systematic review to determine best practice reporting guidelines for AFO interventions in studies involving children with cerebral palsy
  
469
• EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting
  
470
• ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis
  
471
• International Spinal Cord Injury Core Data Set (version 3.0) – including standardization of reporting
  
472
• Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting
  
473
• The importance of uniform venous terminology in reports on varicose veins
  
474
• Recommendations for reporting perioperative transoesophageal echo studies
  
475
• Guidelines for reporting an f MRI study
  
476
• Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations
  
477
• Criteria for evaluation of novel markers of cardiovascular risk
  
478
• American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation
  
479
• Research reporting standards for radioembolization of hepatic malignancies
  
480
• Research reporting standards for image-guided ablation of bone and soft tissue tumors
  
481
• EANM procedure guidelines for brain neurotransmission SPECT using I-labelled dopamine transporter ligands, version 2
  
482
• Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria
  
483
• Reporting standards for percutaneous thermal ablation of renal cell carcinoma
  
484
• Research reporting standards for percutaneous vertebral augmentation
  
485
• Reporting standards for percutaneous interventions in dialysis access
  
486
• Reporting standards for clinical evaluation of new peripheral arterial revascularization devices
  
487
• Guidelines for the reporting of renal artery revascularization in clinical trials
  
488
• Reporting standards for carotid interventions from the Society for Vascular Surgery
  
489
• Reporting standards for carotid artery angioplasty and stent placement
  
490
• Standardized definitions and clinical endpoints in carotid artery and supra-aortic trunk revascularization trials
  
491
• Setting the standards for reporting ruptured abdominal aortic aneurysm
  
492
• Endovascular repair compared with operative repair of traumatic rupture of the thoracic aorta: a nonsystematic review and a plea for trauma-specific reporting guidelines
  
493
• Reporting standards for thoracic endovascular aortic repair (TEVAR)
  
494
• Research reporting standards for endovascular treatment of pelvic venous insufficiency
  
495
• Reporting standards for endovascular treatment of pulmonary embolism
  
496
• Reporting Standards for Endovascular Repair of Saccular Intracranial Cerebral Aneurysms
  
497
• Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke
  
498
• Target registration and target positioning errors in computer-assisted neurosurgery: proposal for a standardized reporting of error assessment
  
499
• Recommended guidelines for reporting on emergency medical dispatch when conducting research in emergency medicine: the Utstein style
  
500
• Recommended guidelines for reviewing, reporting, and conducting research on post-resuscitation care: the Utstein style
  
501
• Utstein-style guidelines for uniform reporting of laboratory CPR research
  
502
• Recommendations for uniform reporting of data following major trauma–the Utstein style
  
503
• Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital ‘Utstein style’
  
504
• Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop
  
505
• EACTS / ESCVS best practice guidelines for reporting treatment results in the thoracic aorta
  
506
• Consensus statement: Defining minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass
  
507
• Guidelines for reporting data and outcomes for the surgical treatment of atrial fibrillation
  
508
• Recommendations for reporting morbid events after heart valve surgery
  
509
• Standards for reporting results of refractive surgery
  
510
• Quality of study methods in individual- and group-level HIV intervention research: critical reporting elements
  
511
• Quality of reporting in evaluations of surgical treatment of trigeminal neuralgia: recommendations for future reports
  
512
• Guidelines for reporting case series of tumours of the colon and rectum
  
513
• Guidance on reporting ultrasound exposure conditions for bio-effects studies
  
514
• American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS)
  
515
• Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group
  
516
• Standardized reporting guidelines for studies evaluating risk stratification of ED patients with potential acute coronary syndromes
  
517
• Calibration methods used in cancer simulation models and suggested reporting guidelines
  
518
• Preschool vision screening: what should we be detecting and how should we report it? Uniform guidelines for reporting results of preschool vision screening studies
  
519
• The lessons of QUANTEC : recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome
  
520
• A reporting guideline for clinical platelet transfusion studies from the BEST Collaborative
  
521
• Clinical trials focusing on cancer pain educational interventions: core components to include during planning and reporting
  
522
• Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR / ACR collaborative recommendations
  
523
• Exercise therapy and low back pain: insights and proposals to improve the design, conduct, and reporting of clinical trials
  
524
• Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate -Specific Antigen Working Group
  
525
• Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
  
526
• Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
  
527
• Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
  
528
• Methodological challenges when using actigraphy in research
  
529
• Draft STROBE checklist for conference abstracts
  
530
• Conflict of Interest in Peer -Reviewed Medical Journals
  
531
• Financial Conflicts of Interest Checklist 2010 for clinical research studies
  
532
• Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest
  
533
• How to formulate research recommendations
  
534
• Suggestions for improving the reporting of clinical research: the role of narrative
  
535
• The case for structuring the discussion of scientific papers
  
536
• More medical journals should inform their contributors about three key principles of graph construction
  
537
• Figures in clinical trial reports: current practice & scope for improvement
  
538
• Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature
  
539
• Reporting results of latent growth modeling and multilevel modeling analyses: some recommendations for rehabilitation psychology
  
540
• Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls
  
541
• Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
  
542
• Statistics in medicine–reporting of subgroup analyses in clinical trials
  
543
• Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study
  
544
• Bayesian methods in health technology assessment: a review
  
545
• Basic Statistical Reporting for Articles Published in Biomedical Journals: The “Statistical Analyses and Methods in the Published Literature” or The SAMPL Guidelines
  
546
• Establishing a knowledge trail from molecular experiments to clinical trials
  
547
• Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers
  
548
• Best practices in the reporting of participatory action research: Embracing both the forest and the trees
  
549
• A comprehensive checklist for reporting the use of OSCEs
  
550
• Quality of standardised patient research reports in the medical education literature: review and recommendations
  
551
• Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data
  
552
• Perspective: Guidelines for reporting team-based learning activities in the medical and health sciences education literature
  
553
• Authors’ Submission Toolkit: a practical guide to getting your research published
  
554
• Good Publication Practice (GPP) Guidelines for Company -Sponsored Biomedical Research: 2022 Update
  
555
• Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization
  
556
• A new structure for quality improvement reports
  
557
• Guidelines for conducting and reporting economic evaluation of fall prevention strategies
  
558
• Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics
  
559
• Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting
  
560
• Reporting format for economic evaluation. Part II : Focus on modelling studies
  
561
• Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies
  
562
• Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report
  
563
• Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost -Effectiveness in Health and Medicine
  
564
• The quality of mixed methods studies in health services research
  
565
• Qualitative research review guidelines – RATS
  
566
• Evolving guidelines for publication of qualitative research studies in psychology and related fields
  
567
• Revealing the wood and the trees: reporting qualitative research
  
568
• Qualitative research: standards, challenges, and guidelines
  
569
• RAMESES publication standards: meta-narrative reviews
  
570
• RAMESES publication standards: realist syntheses
  
571
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group
  
572
• Meta-analysis of individual participant data: rationale, conduct, and reporting
  
573
• PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity
  
574
• PRISMA 2020 for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts
  
575
• The STARD statement for reporting diagnostic accuracy studies: application to the history and physical examination
  
576
• Capturing momentary, self-report data: a proposal for reporting guidelines
  
577
• Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES)
  
578
• Guidelines for field surveys of the quality of medicines: a proposal
  
579
• A guide for the design and conduct of self-administered surveys of clinicians
  
580
• Good practice in the conduct and reporting of survey research
  
581
• Reporting genetic results in research studies: summary and recommendations of an NHLBI working group
  
582
• Recommendations for biomarker identification and qualification in clinical proteomics
  
583
• Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines
  
584
• Gene expression-based prognostic signatures in lung cancer: ready for clinical use?
  
585
• Anecdotes as evidence
  
586
• Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine
  
587
• Guidelines for submitting adverse event reports for publication
  
588
• Guidelines for clinical case reports in behavioral clinical psychology
  
589
• Instructions to authors for case reporting are limited: a review of a core journal list
  
590
• Reporting participation in case-control studies
  
591
• Conducting and reporting case series and audits–author guidelines for acupuncture in medicine
  
592
• Appropriate use and reporting of uncontrolled case series in the medical literature
  
593
• Improving the reporting of clinical case series
  
594
• EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
  
595
• Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology
  
596
• A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement
  
597
• STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME) : An extension of the STROBE statement
  
598
• STrengthening the REporting of Genetic Association Studies (STREGA) : An Extension of the STROBE Statement.
  
599
• Guidelines for conducting and reporting mixed research in the field of counseling and beyond
  
600
• Reporting experiments in homeopathic basic research (REHBaR) – a detailed guideline for authors
  
601
• Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods
  
602
• Good research practices for comparative effectiveness research: Defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources
  
603
• Guidelines for reporting non-randomised studies
  
604
• Setting the bar in phase II trials: the use of historical data for determining “go/no go” decision for definitive phase III testing
  
605
• GNOSIS : Guidelines for Neuro -Oncology : Standards for Investigational Studies – reporting of surgically based therapeutic clinical trials
  
606
• The standard of reporting of health-related quality of life in clinical cancer trials
  
607
• A systematic review of the reporting of Data Monitoring Committees’ roles, interim analysis and early termination in pediatric clinical trials
  
608
• “Brimful of STARLITE ”: toward standards for reporting literature searches
  
609
• Systematic prioritization of the STARE-HI reporting items. An application to short conference papers on health informatics evaluation
  
610
• CONSORT-EHEALTH : improving and standardizing evaluation reports of Web-based and mobile health interventions
  
611
• Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension
  
612
• Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
  
613
• Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ
  
614
• Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal
  
615
• Relevance of CONSORT reporting criteria for research on eHealth interventions
  
616
• Reporting guidelines for music-based interventions
  
617
• Reporting whole-body vibration intervention studies: recommendations of the International Society of Musculoskeletal and Neuronal Interactions
  
618
• Reporting standards for studies of tailored interventions
  
619
• Reporting data on homeopathic treatments (RedHot) : A supplement to CONSORT
  
620
• Evaluating the quality of reporting occupational therapy randomized controlled trials by expanding the CONSORT criteria
  
621
• WIDER recommendations for reporting of behaviour change interventions
  
622
• Evidence-based behavioral medicine: what is it and how do we achieve it?
  
623
• CONSORT 2010: CONSORT-C (children)
  
624
• The CONSORT statement checklist in allergen-specific immunotherapy: a GA 2 LEN paper
  
625
• Improving the reporting of pragmatic trials: an extension of the CONSORT statement
  
626
• CONSORT for reporting randomised trials in journal and conference abstracts
  
627
• CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts
  
628
• Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT Statement
  
629
• Consort 2010 statement: extension to cluster randomised trials
  
630
• Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement
  
631
• Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) : extending the CONSORT statement
  
632
• STARE-HI – Statement on reporting of evaluation studies in Health Informatics
  
633
• The ORION statement: guidelines for transparent reporting of Outbreak Reports and Intervention studies Of Nosocomial infection
  
634
• Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
  
635
• Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
  
636
• Reporting and presenting information retrieval processes: the need for optimizing common practice in health technology assessment
  
637
• Guidelines for reporting reliability and agreement studies (GRRAS) were proposed
  
638
• SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process
  
639
• Refining a checklist for reporting patient populations and service characteristics in hospice and palliative care research
  
640
• Point and interval estimates of effect sizes for the case-controls design in neuropsychology: rationale, methods, implementations, and proposed reporting standards
  
641
• Recommended guidelines for uniform reporting of pediatric advanced life support: the pediatric Utstein style
  
642
• Consolidated criteria for reporting qualitative research (COREQ) : a 32-item checklist for interviews and focus groups
  
643
• Guidelines for reporting results of quality of life assessments in clinical trials
  
644
• Recommendations for reporting economic evaluations of haemophilia prophylaxis
  
645
• Overview of methods used in cross-cultural comparisons of menopausal symptoms and their determinants: Guidelines for Strengthening the Reporting of Menopause and Aging (STROMA) studies
  
646
• Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement
  
647
• GNOSIS : guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials
  
648
• Standard guidelines for publication of deep brain stimulation studies in Parkinson’s disease (Guide 4 DBS-PD)